Report Highlights
- The total market for drugs and cosmetics for aging boomers, as defined in this study, will reach an estimated $28.5 billion in sales in 2001.
- This market is expected to grow to $41.94 billion in 2006 at an average annual rate (AAGR) of 8%.
- The market with the highest projected AAGR (16.5%) is hormone replacement therapy. The numbers of those seeking relief from menopausal symptoms is steadily increasing.
- Other rapidly growing market segments are arthritis therapies, vision-related products, urinary incontinence products, skin care products and periodontal disease therapies.
- Boomers will be the best educated seniors in history and are expected to enjoy better health later in life as a result of better self-help and preventative activities.
INTRODUCTION
STUDY GOAL AND OBJECTIVES
This study provides readers with an intensive examination of the growing market for drugs and cosmetics for aging boomers.
Not only does the report focus on the demographics and behavior patterns of the baby boomer generation but it also examines the group's significance as a major market segment within the United States drug and cosmetics industries. From this analysis, BCC provides estimates for current and future trends in market size, market participants, product lines and consumer attitudes.
REASONS FOR DOING THIS STUDY
Dramatic changes are taking place as "baby boomers" approach "old age." Many boomers are now over 50 and if one expands the definition to include the "war-baby" cohort then many are retired and about to receive Social Security. This generation has not mimicked preceding generations but has been one of trendsetters. Its members have a high participation rate in sports activities and are very exercise oriented. Consequently, in addition to experiencing the problems associated with aging, they will experience many sports-related problems.
Also, the concept of "looking one's age" does not appeal to a large number of members of this demographic, both male and female, and their reliance on cosmetic products already has been demonstrated. It is BCC's goal to fully identify and examine these trends and to forecast future market changes through 2006.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study defines the major markets driven by "baby boomers" and provides detailed information on:
- drugs used to treat or prevent age-related disorders
- vitamins, nutritionals and herbals targeted to senior citizens
- hormone replacement therapy and other menopausal therapies
- prostate medications
- hair regrowth products
- impotency treatments
- skin care and antiwrinkle products
- sunscreen products.
This study will prove particularly beneficial to pharmaceutical and cosmetics industry participants who hold marketing, management and technical development positions. It also will benefit readers who are suppliers to these industries as well as investors, venture capitalists, and those interested in demographic trends within these industries.
SCOPE AND FORMAT
Included in this study are all products classified as drugs and cosmetics. These include products sold over-the-counter or by prescription. Also included are vitamins and herbal remedies, although these are not considered drugs.
These markets are defined in light of current and potential products, market segments, governmental and regulatory agencies, major companies competing in this market, relative market shares and impact of the worldwide market status.
METHODOLOGY AND INFORMATION SOURCES
The primary data collection method for this report focuses on interviews with industry and trade personnel, company sources, annual reports, government agency personnel, industry observers, scientists and industry professional organizations, as well as a survey of the retail markets. In addition to these primary data sources, secondary data research techniques included a literature search of BCC's extensive library, as well as medical and libraries.
All data were analyzed by BCC personnel to determine specific findings and to make forecasts. Once these forecasts were obtained, they were validated by consultation with industry experts. Consequently, all estimates provided in this report represent a consensus opinion of BCC personnel, industry participants and industry observers. Growth forecasts are made in constant 2001 dollars based on the U.S. manufacturers' (wholesale) price level unless otherwise noted.
Related Reports
Recent Reports
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More